Q2 2018 Holdings
Filed 2018-08-14 | 25 holdings | $16.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals(CPIX) | COM | 230770109 | $7.4M | 1,203,339 | 43.5% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $3.8M | 831,731 | 22.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $3.0M | 194,900 | 17.6% |
| Alphatec Holdings Inc(ATEC) | COM NEW | 02081G201 | $2.7M | 903,224 | 15.9% |
| Biospecifics Technologies(BSTC) | COM | 090931106 | $20.7K | 461,315 | 0.1% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $20.2K | 4,049,298 | 0.1% |
| Apollo Endosurgery Inc(HQ8F) | COM | 03767D108 | $18.0K | 2,577,996 | 0.1% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $17.5K | 5,670,205 | 0.1% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $11.4K | 600,000 | 0.1% |
| Viveve Medical Inc | COM NEW | 92852W204 | $10.5K | 3,849,711 | 0.1% |
| Correvio Pharma Corp | COM | 22026V105 | $7.3K | 1,930,022 | 0.0% |
| Alimera Sciences Inc | COM | 016259103 | $6.8K | 6,981,184 | 0.0% |
| Novelion Therapeutics Inc | COM NEW | 67001K202 | $6.6K | 1,792,911 | 0.0% |
| HTG Molecular Diagnostics | COM | 40434H104 | $5.5K | 1,689,064 | 0.0% |
| Ophthotech Corp | COM | 683745103 | $5.2K | 1,912,018 | 0.0% |
| Biodelivery Sciences Intl(BDSIUSD) | COM | 09060J106 | $4.4K | 1,486,002 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $4.2K | 1,496,590 | 0.0% |
| Catabasis Pharmaceuticals in | COM | 14875P107 | $2.3K | 2,400,000 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $2.2K | 425,531 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $1.4K | 198,373 | 0.0% |
| Cancer Genetics Inc(CGIXUSD) | COM | 13739U104 | $1.2K | 1,391,607 | 0.0% |
| Gemphire Therapeutics Inc | COM | 36870A108 | $1.1K | 103,000 | 0.0% |
| Conformis Inc(CFMS) | COM | 20717E101 | $770 | 616,109 | 0.0% |
| Melinta Therapeutics Inc | COM | 58549G100 | $331 | 52,200 | 0.0% |
| Invivo Therapeutics Holdings | COM PAR | 46186M407 | $132 | 77,900 | 0.0% |